Search

Issue
Title
Authors
Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study
Samoylenko I.V., Demidov L.V., Moiseenko F.V., Dvorkin M.V., Demidova S.A., Protsenko S.A., Stroyakovskiy D.L., Kozlov V.V., Odintsova S.V., Kirtbaya D.V., Tantsyrev D.A., Mochalova A.S., Orlova R.V., Mukhametshina G.Z., Fadeeva N.V., Fomin E.A., Chapko Y.S., Tarasova A.V., Ermakov N.B., Shemerovskiy A.K., Vaschenko V.A., Chistyakov V.M., Zinkina-Orikhan A.V., Lin'kova Y.N., Kryukov F.B., Sorokina I.V., Siliutina A.A.
Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis
Lyadova M.A., Fedorinov D.S., Kuzmina E.S., Antonova T.G., Sokolskaya V.K.
Place of durvalumab in the treatment of biliary tract cancer: A review
Breder V.V., Ledin E.V., Chubenko V.A., Orlova R.V., Petkau V.V., Pokataev I.A.
News in immunotherapy for metastatic melanoma: prolgolimab in clinical practice (authors' experience)
Oganesyan L.V., Karnaukhov N.S., Feoktistova P.S.
Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
CAR NK-сells for the treatment of hematological malignancies: A review
Gribkova I.V.
Can bispecific antibodies change the paradigm and goals of therapy for patients with relapsed non-Hodgkin lymphomas?
Poddubnaya I.V.
Creating a story on the pages of a book about diffuse B-large cell lymphoma
Editorial B.
The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021
Editorial B.
Clinical case of complications of immunotherapy – encephalitis
Lyadova M.A., Kuchevskaya O.A., Kulikova E.A.
Treatment of advanced small cell lung cancer. Clinical case and literature review
Menshikov K.V., Sultanbaev A.V., Musin S.I., Menshikova I.A., Nasretdinov A.F., Sultanbaeva N.I.
Immunotherapy in combination with chemotherapy in triple-negative breast cancer - the first “target” therapy for the “target” patients’ population
Grechukhina K.S., Zhukova L.G.
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
Ignatova A.V.
Durvalumab in the treatment of locally advanced non-small cell lung cancer after chemoradiotherapy in a real practice
Sakaeva D.D., Ruchkin V.V., Goncharova O.V., Abbasova R.R., Mufazalov F.F.
Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS)
Ziganshin A.U.
BCD-100 - first russian PD-1 inhibitor
Tyulyandin S.A., Fedyanin M.Y., Semiglazova T.Y., Moiseenko V.M., Odintsova S.V., Alekseev B.Y., Ivanov R.A., Shustova M.S.
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
Ganshina I.P., Gordeeva O.O., Manukian M.S.
The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?
Sarzhevskiy V.O., Melnichenko V.I., Panshina I.V., Mochkin N.E., Bogatyrov V.S., Borshevetskaya M.M., Smirnova E.G., Bannikova A.E., Samoylova A.A., Mamedova A.A., Rukavitsin A.A., Vasilev S.S., Bronov O.I.
The relationship of GITR, Lag-3 and PD-1 expression with the main indicators of systemic and local immunity in patients with breast cancer
Tabakov D.V., Zabotina T.N., Chanturia N.V., Zakharova E.N., Vorotnikov I.K., Selchuk V.Y., Sokolovskiy V.V., Petrovsky A.V.
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
Yudin D.I., Laktionov K.K., Laktionova L.V., Breder V.V.
Use of nivolumab for colon cancer with Lynch syndrome
Khakimov G.A., Tryakin A.A., Khakimova G.G.
Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features
Reutova E.V., Laktionov K.K.
Opportunities for metastatic triple negative breast cancer therapy
Ganshina I.P., Gordeeva O.O., Manukyan M.S.
Hodgkin lymphoma. ASCO, EHA and ASH 2020 news
Demina E.A.
Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer
Statsenko G.B., Kurakin V.I., Plokhotenko I.V.
1 - 25 of 25 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies